LIGANDS THAT TARGET HCV-E2 BINDING SITES ON CD-81 AND THERAPEUTIC METHODS USING THEM
- Detailed Technology Description
- None
- *Abstract
-
None
- *Publications
- Al Olaby RR, Cocquerel L, Zemla A, Saas L, Dubuisson J, Vielmetter J, Marcotrigiano J, Khan AG, Catalan FV, Perryman AL, Freundlich JS, Forli S, Levy S, Balhorn R, Azzazy HM. (2014) Identification of a Novel Drug Lead That Inhibits HCV Infection and Cell-to-Cell Transmission by Targeting the HCV E2 Glycoprotein. PLoS One. 2014 Oct 30;9(10):e111333. doi: 10.1371/journal.pone.0111333. eCollection 2014.
- Country/Region
- USA
For more information, please click Here

